Bioventus Stock Number Of Shares Shorted
| BVS Stock | USD 6.18 0.34 5.21% |
Fundamental analysis of Bioventus allows traders to better anticipate movements in Bioventus' stock price by examining its financial health and performance throughout various phases of its business cycle.
Bioventus | Build AI portfolio with Bioventus Stock |
Bioventus Company Number Of Shares Shorted Analysis
Bioventus' Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
Current Bioventus Number Of Shares Shorted | 1.59 M |
Most of Bioventus' fundamental indicators, such as Number Of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bioventus is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
| Competition |
Based on the recorded statements, Bioventus has 1.59 M of outstending shares currently sold short by investors. This is 50.32% lower than that of the Health Care Equipment & Supplies sector and 42.95% lower than that of the Health Care industry. The number of shares shorted for all United States stocks is 66.22% higher than that of the company.
Bioventus Number Of Shares Shorted Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bioventus' direct or indirect competition against its Number Of Shares Shorted to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bioventus could also be used in its relative valuation, which is a method of valuing Bioventus by comparing valuation metrics of similar companies.Bioventus is currently under evaluation in number of shares shorted category among its peers.
Bioventus Fundamentals
| Return On Equity | -0.2 | ||||
| Return On Asset | 0.0333 | ||||
| Profit Margin | (0.06) % | ||||
| Operating Margin | 0.04 % | ||||
| Current Valuation | 775.98 M | ||||
| Shares Outstanding | 66.36 M | ||||
| Shares Owned By Insiders | 11.86 % | ||||
| Shares Owned By Institutions | 72.36 % | ||||
| Number Of Shares Shorted | 1.59 M | ||||
| Price To Earning | 6.96 X | ||||
| Price To Book | 2.92 X | ||||
| Price To Sales | 0.76 X | ||||
| Revenue | 573.28 M | ||||
| Gross Profit | 382.9 M | ||||
| EBITDA | (49.55 M) | ||||
| Net Income | (33.54 M) | ||||
| Cash And Equivalents | 34.36 M | ||||
| Cash Per Share | 0.56 X | ||||
| Total Debt | 335.63 M | ||||
| Debt To Equity | 1.17 % | ||||
| Current Ratio | 0.94 X | ||||
| Book Value Per Share | 2.24 X | ||||
| Cash Flow From Operations | 38.8 M | ||||
| Short Ratio | 3.49 X | ||||
| Earnings Per Share | (0.48) X | ||||
| Price To Earnings To Growth | 2.14 X | ||||
| Target Price | 12.25 | ||||
| Number Of Employees | 930 | ||||
| Beta | 0.84 | ||||
| Market Capitalization | 432.65 M | ||||
| Total Asset | 727.96 M | ||||
| Retained Earnings | (355.08 M) | ||||
| Working Capital | 65.21 M | ||||
| Net Asset | 727.96 M |
About Bioventus Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bioventus's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bioventus using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bioventus based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Bioventus Stock Analysis
When running Bioventus' price analysis, check to measure Bioventus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioventus is operating at the current time. Most of Bioventus' value examination focuses on studying past and present price action to predict the probability of Bioventus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioventus' price. Additionally, you may evaluate how the addition of Bioventus to your portfolios can decrease your overall portfolio volatility.